Systematic review of the molecular basis for cavernous sinus invasion in somatotropinomas
Endocrine-Related Cancer · 01.05.2026 · 33 (5)
DOI: 10.1530/erc-25-0236 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Endocrine-Related Cancer, online erschienen am 16.04.2026. Verfasst von Christopher Dillon Ovenden und 11 weiteren Autor:innen. Beteiligte Einrichtung: Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, Australia. Hauptthemen laut MEDLINE: Cavernous Sinus, Growth Hormone-Secreting Pituitary Adenoma, Adenoma, Pituitary Neoplasms. Die Arbeit nennt 92 Literaturangaben.
Abstract (Originalsprache)
Somatotropinomas are a subtype of pituitary adenomas that have a particular predilection to invade the cavernous sinus. The objective of this systematic review was to examine the evidence regarding the molecular basis for cavernous sinus invasion in somatotropinomas. This review was conducted in accordance with the 2020 PRISMA guidelines on 13 April 2025. Inclusion criteria were reports of associations between somatotropinoma molecular changes and cavernous sinus invasion in adult patients. Title/abstract screening and full-text screening were performed, with studies assessed for risk of bias using the Newcastle–Ottawa scale. A total of 43 studies were identified, encompassing 1,824 patients (724 invasive tumours). Overall, 33 studies identified molecules that were upregulated in invasive tumours and 20 studies identified molecules that were downregulated. Few studies incorporated modern proteomic or transcriptomic techniques. Risk of bias was low with a mean Newcastle–Ottawa scale score of 7.0 (±0.6). Molecules associated with invasion were related to epithelial–mesenchymal transition (E-cadherin, ESRP1, fascin-1, and MMP-9), cellular proliferation (PTTG, AIP, TCERG1, EIF2β, E2F1, Notch 2, STAT3, ARRB1, TGFB1, SMAD3, SOX9, SGK1, MAGEA6 DLL3, EGFL7, and pEGFR), hormonal signalling (GNAS, DRD5, DRD1, sst5TMD4, SSTR2, and SSTR5), and tumour angiogenesis (VEGF and Drp1). These molecular variations present a possible explanation for the proclivity of somatotropinomas for the cavernous sinus. Identified molecules represent options for novel targeted therapies or biomarkers that could inform prognostication. Modern proteomic and transcriptomic techniques and larger somatotropinoma datasets are required to further elucidate the molecular pathways responsible for cavernous sinus invasion in somatotropinomas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, Australia.
- Centre for Cancer Biology, University of South Australia, Adelaide, Australia.
- Department of Surgery, Monash University, Melbourne, Australia.
- Department of Neurosurgery, Monash Health, Melbourne, Australia.
- Department of Neurosurgery, Flinders Medical Centre, Adelaide, Australia.
- Department of Neurosurgery, Royal Adelaide Hospital, Adelaide, Australia.
ORCID-Profile: Christopher Dillon Ovenden, Sunita De Sousa
Zitieren
APA
Ovenden, C. D., Candy, N., Bacchi, S., Sorvina, A., Castle-Kirszbaum, M., Poonnoose, S., Vrodos, N., Jukes, A., Santoreneos, S., Torpy, D. J., Psaltis, A., & De Sousa, S. (2026). Systematic review of the molecular basis for cavernous sinus invasion in somatotropinomas. Endocrine-Related Cancer, 33(5). https://doi.org/10.1530/erc-25-0236
Vancouver
Ovenden CD, Candy N, Bacchi S, Sorvina A, Castle-Kirszbaum M, Poonnoose S, et al. Systematic review of the molecular basis for cavernous sinus invasion in somatotropinomas. Endocrine-Related Cancer. 2026;33(5). doi:10.1530/erc-25-0236
BibTeX
@article{Ovenden2026,
author = {Ovenden, Christopher Dillon and Candy, Nicholas and Bacchi, Stephen and Sorvina, Alexandra and Castle-Kirszbaum, Mendel and Poonnoose, Santosh and Vrodos, Nikitas and Jukes, Alistair and Santoreneos, Stephen and Torpy, David J and Psaltis, Alkis and De Sousa, Sunita},
title = {Systematic review of the molecular basis for cavernous sinus invasion in somatotropinomas},
journal = {Endocrine-Related Cancer},
year = {2026},
volume = {33},
number = {5},
doi = {10.1530/erc-25-0236}
}
EUVIMED